Routman, David M.
Jusue-Torres, Ignacio
Brown, Paul D.
Trifiletti, Daniel M.
Vora, Sujay A.
Brown, Desmond A.
Parney, Ian F.
Burns, Terry C.
Yan, Elizabeth
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NIH NCI P30CA015083, NIH NCI P30CA015083, NIH NCI P30CA015083, NIH NCI P30CA015083, NIH NCI P30CA015083, NIH NCI P30CA015083, NIH NCI P30CA015083, NIH NCI P30CA015083, NIH NCI P30CA015083)
Mayo Clinic Comprehensive Cancer Center
Article History
Received: 2 June 2023
Accepted: 26 February 2024
First Online: 12 March 2024
Declarations
:
: This study is approved by the Institutional Review Board of Mayo Clinic and adheres to the quality standards set by the Good Clinical Practice guidelines. This study is conducted in accordance with the Declaration of Helsinki. Written informed consent is/will be obtained from every participant in this study, and it’s part of the inclusion/exclusion criteria.
: Not applicable.
: The authors declare no competing interests.